These direct benefits were recently confirmed by the publication of the results of a large Phase III vaccine trial of Gardasil in 16-26 year old men. The study, which appeared in the February 3 issue of the New England Journal of Medicine, found that Gardasil was quite effective in reducing genital warts in men who had not been previously exposed to the covered types of HPV. This adds to the evidence which, only last month, led to the FDA approval of the vaccine for preventing anal cancer in both men and women.
Right now, universal vaccination of young men is unlikely to be recommended for a variety of reasons - including the fact that the vaccine is expensive and vaccination simply may not be a cost effective solution to HPV related health problems. Still, there is a growing amount of evidence that HPV vaccination may be, at least, worth talking about with your teenage sons. If nothing else, doing so may be a good way to initiate important discussions of safe sex.
- The HPV Vaccine in Men
- HPV & Throat Cancer
- HPV in Men
- FDA Approves Gardasil To Prevent Anal Cancer
- What Are Genital Warts?
- Using Gardasil To Talk About Safe Sex